A detailed history of Oak Ridge Investments LLC transactions in Glaukos Corp stock. As of the latest transaction made, Oak Ridge Investments LLC holds 10,473 shares of GKOS stock, worth $942,884. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,473
Previous 10,695 2.08%
Holding current value
$942,884
Previous $1.1 Million 22.64%
% of portfolio
0.06%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

SELL
$79.92 - $106.55 $17,742 - $23,654
-222 Reduced 2.08%
10,473 $854,000
Q2 2025

Jul 25, 2025

SELL
$82.27 - $103.29 $33,072 - $41,522
-402 Reduced 3.62%
10,695 $1.1 Million
Q1 2025

May 13, 2025

SELL
$96.6 - $161.22 $5,119 - $8,544
-53 Reduced 0.48%
11,097 $1.09 Million
Q4 2024

Jan 15, 2025

BUY
$126.42 - $152.67 $1.41 Million - $1.7 Million
11,150 New
11,150 $1.67 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.29B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.